Selected article for: "ifn response and innate response"

Author: Arkin, Lisa M.; Moon, John J.; Tran, Jennifer M.; Asgari, Samira; O’Farrelly, Cliona; Casanova, Jean-Laurent; Cowen, Edward W.; Mays, Jacqueline W.; Singh, Anne Marie; Drolet, Beth A.
Title: From your nose to your toes: A Review of SARS-CoV-2 Pandemic-associated Pernio
  • Cord-id: 0giadhrs
  • Document date: 2021_7_15
  • ID: 0giadhrs
    Snippet: Despite thousands of reported patients with pandemic-associated pernio, low rates of seroconversion and PCR positivity have defied causative linkage to SARS-CoV-2. Pernio in uninfected children is associated with monogenic disorders of excessive type 1 interferon (IFN-1) immunity, while severe COVID-19 pneumonia can result from insufficient IFN-1. Moreover, SARS-CoV-2 spike protein and robust IFN-1 response are seen in the skin of pandemic-associated pernio, suggesting an excessive innate immune
    Document: Despite thousands of reported patients with pandemic-associated pernio, low rates of seroconversion and PCR positivity have defied causative linkage to SARS-CoV-2. Pernio in uninfected children is associated with monogenic disorders of excessive type 1 interferon (IFN-1) immunity, while severe COVID-19 pneumonia can result from insufficient IFN-1. Moreover, SARS-CoV-2 spike protein and robust IFN-1 response are seen in the skin of pandemic-associated pernio, suggesting an excessive innate immune skin response to SARS-CoV-2. Understanding the pathophysiology of this phenomenon may elucidate host mechanisms that drive a resilient immune response to SARS-CoV-2 and could produce relevant therapeutic targets.

    Search related documents:
    Co phrase search for related documents
    • acid sensing and acute respiratory: 1, 2, 3, 4, 5
    • acral site and acute infection: 1
    • acute infection and adaptive immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute infection and local response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute infection and long history: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute infection and low amount: 1
    • acute infection and lymphocytic infiltrate: 1
    • acute respiratory and adaptive immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and local response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and long history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and low amount: 1, 2, 3, 4
    • acute respiratory and lymphocytic infiltrate: 1, 2, 3, 4
    • adaptive immune system and local response: 1, 2
    • adaptive immune system and low amount: 1